Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:59 pm Purchase |
2023-12-29 | 13G | Axonics, Inc. AXNX |
The Vanguard Group | 5,260,830 10.380% |
167,942 (+3.30%) |
Filing History |
| 2024-02-12 12:03 pm Sale |
2024-02-09 | 13G | Axonics, Inc. AXNX |
FMR CORP | 1,179,132 2.322% |
-4,246,873 (-78.27%) |
Filing History |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Axonics, Inc. AXNX |
FMR CORP | 5,426,005 10.710% |
-91,421 (-1.66%) |
Filing History |
| 2024-01-25 4:59 pm Purchase |
2023-12-31 | 13G | Axonics, Inc. AXNX |
BLACKROCK INC BLK |
4,189,817 8.300% |
558,974 (+15.40%) |
Filing History |
| 2023-12-11 09:09 am Purchase |
2023-12-08 | 13G | Axonics, Inc. AXNX |
FMR CORP | 5,517,426 10.890% |
2,798,634 (+102.94%) |
Filing History |
| 2023-03-10 07:59 am Purchase |
2023-02-28 | 13G | Axonics, Inc. AXNX |
The Vanguard Group | 5,092,888 10.280% |
229,605 (+4.72%) |
Filing History |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Axonics, Inc. AXNX |
The Vanguard Group | 4,863,283 9.820% |
1,960,587 (+67.54%) |
Filing History |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | Axonics, Inc. AXNX |
FMR CORP | 2,718,792 5.489% |
-1,200,592 (-30.63%) |
Filing History |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Axonics, Inc. AXNX |
BLACKROCK INC BLK |
3,630,843 7.300% |
105,294 (+2.99%) |
Filing History |
| 2022-06-06 06:06 am Sale |
2022-06-06 | 13G | Axonics, Inc. AXNX |
Cooperatieve Gilde Healthcare IV U.A. | 0 0.000% |
-1,376,733 (Position Closed) |
Filing History |
| 2022-02-14 1:11 pm Sale |
2021-12-31 | 13G | Axonics, Inc. AXNX |
CREDIT SUISSE FIRST BOSTON | 2,273,198 4.900% |
-257,783 (-10.19%) |
Filing History |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Axonics, Inc. AXNX |
The Vanguard Group | 2,902,696 6.270% |
2,902,696 (New Position) |
Filing History |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | Axonics, Inc. AXNX |
FMR CORP | 3,919,384 8.465% |
-938,522 (-19.32%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Axonics, Inc. AXNX |
BLACKROCK INC BLK |
3,525,549 7.600% |
1,246,316 (+54.68%) |
Filing History |
| 2021-04-08 4:32 pm Sale |
2020-12-31 | 13G | Axonics, Inc. AXNX |
Alfred E. Mann Foundation for Scientific Research | 1,602,970 4.000% |
-224,598 (-12.29%) |
Filing History |
| 2021-02-12 4:19 pm Purchase |
2020-12-31 | 13G | Axonics, Inc. AXNX |
CREDIT SUISSE FIRST BOSTON | 2,530,981 6.360% |
2,530,981 (New Position) |
Filing History |
| 2021-02-12 12:33 pm Sale |
2020-12-31 | 13G | Axonics, Inc. AXNX |
Flynn James E | 800,000 2.010% |
-994,594 (-55.42%) |
Filing History |
| 2021-02-08 10:17 am Purchase |
2021-02-05 | 13G | Axonics, Inc. AXNX |
FMR CORP | 4,857,906 12.202% |
168,080 (+3.58%) |
Filing History |
| 2021-02-08 10:00 am Sale |
2020-12-31 | 13G | Axonics, Inc. AXNX |
Cooperatieve Gilde Healthcare IV U.A. | 1,376,733 3.500% |
-1,756,599 (-56.06%) |
Filing History |
| 2021-02-05 4:31 pm Sale |
2020-12-31 | 13G | Axonics, Inc. AXNX |
Integrated Core Strategies (US) LLC | 31,524 0.100% |
-1,903,614 (-98.37%) |
Filing History |